BIOSYNTHESIS OF BACTERIAL CELL WALLS AND MEMBRANES
Project Number5R01AI005044-26
Contact PI/Project LeaderSHOCKMAN, GERALD D
Awardee OrganizationTEMPLE UNIV OF THE COMMONWEALTH
Description
Abstract Text
We will continue to study aspects of the biosynthesis, assembly and
degradation of the bacteria cell wall, especially in relationship
to cell growth and cell division. Emphasis will be placed on
studies of Streptococcus faecium ATCC 9790 as a "model system,"
particularly because of its relatively simple shape and mode of
division. Studies during the next 5-year grant period will be
directed towards studies of the possible roles of two separate and
distinct muramidases of SF in surface assembly and division. Thus
we propose to: (i) Study several of the properties of the two very
unusual autolytic murasidases of SF. Included will be studies of
the molecular mechanism of hydrolysis of PGs by muramidase-2 (E-
2). The possibility that E-2 is a transglycosidase is of
particular interest, as is the possibility that E-2 is a "two-
headed" type of transglycosidase-transpeptidase, similar to at
least two of the penicillin-binding proteins (PBPs) of Escherichia
coli. Additionally we will study and compare the binding of and
catalytic properties of both E-l and E-2 on a number of different
soluble and insoluble substrates. The ultimate goal of these
studies is to obtain an insight into the action of and regulation
of these two activities in growing and dividing bacteria. (ii)
Study the possible in vivo functions of these two, redundant, PG
hydrolases in cell wall assembly, surface enlargement and/or cell
division. Towards this goal we will obtain and characterize
isogenic pairs, one of which will contain a mutation in the
structural gene for E-1 or E-2. The genes for E-l and E-2 will be
cloned in E. coli and the two genes will be sequenced. (iii)
Additional studies will include investigations of the relationship
of E-2 to PBPs, and studies of cell wall organization using
monoclonal antibodies to epitopes present in the cell wall PG.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
057123192
UEI
QD4MGHFDJKU1
Project Start Date
01-January-1978
Project End Date
31-March-1993
Budget Start Date
01-April-1989
Budget End Date
31-March-1990
Project Funding Information for 1989
Total Funding
$212,244
Direct Costs
$136,457
Indirect Costs
$75,787
Year
Funding IC
FY Total Cost by IC
1989
National Institute of Allergy and Infectious Diseases
$212,244
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI005044-26
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI005044-26
Patents
No Patents information available for 5R01AI005044-26
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI005044-26
Clinical Studies
No Clinical Studies information available for 5R01AI005044-26
News and More
Related News Releases
No news release information available for 5R01AI005044-26
History
No Historical information available for 5R01AI005044-26
Similar Projects
No Similar Projects information available for 5R01AI005044-26